What is Jonathan D Root's role at Edgewise Therapeutics, Inc.?

Jonathan D Root reports to the SEC as director at Edgewise Therapeutics, Inc. (EWTX), according to the latest filing on July 17, 2026. Jonathan D Root has also filed as director at Omada Health, Inc. (OMDA), director at Carlsmed, Inc. (CARL), director at Inari Medical, Inc. (NARI) and director at Silverback Therapeutics, Inc. (SPRY).

How many shares does Jonathan D Root own?

After the latest filing that states it, Jonathan D Root directly owned 15,625 shares of Edgewise Therapeutics, Inc. (EWTX), 191,877 shares of Omada Health, Inc. (OMDA), 497,697 shares of Carlsmed, Inc. (CARL) and 95,238 shares of Silverback Therapeutics, Inc. (SPRY). Shares held through trusts, funds or family members are reported separately and are not counted here.

Has Jonathan D Root bought or sold stock recently?

The most recent open-market purchase was on July 24, 2025: bought 466,666 shares of Carlsmed, Inc. (CARL) for $7M at an average of $15.00. The most recent open-market sale was on December 2, 2021: sold 8,113 shares of eFFECTOR Therapeutics, Inc. (EFTR) for $46.1K at an average of $5.68.

How do I get alerts when Jonathan D Root files?

Follow Jonathan D Root on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

Insiders · EWTX

Jonathan D Root

Director at Edgewise Therapeutics, Inc. (EWTX)

Jonathan D Root has filed 38 insider reports with the SEC since January 2021, as director at Edgewise Therapeutics, Inc. (EWTX), director at Omada Health, Inc. (OMDA) and director at Carlsmed, Inc. (CARL) and at 4 more companies. Jonathan D Root made no open-market purchases or sales in the last 12 months. The latest filing, on July 17, 2026, reports grant or award at Edgewise Therapeutics, Inc. (EWTX).

Filings: 38
Companies: 7
Bought on market: $7.06M
Sold on market: $2.48M

Companies where Jonathan D Root is an insider

Company	Role	Shares held	Bought	Sold	Avg buy	Price now	Last filing
EWTX Edgewise Therapeutics, Inc.	Director	15,625				$45.04	Jul 17, 2026
OMDA Omada Health, Inc.	Director	191,877				$15.09	Jul 7, 2026
CARL Carlsmed, Inc.	Director	497,697	$7M		$15.00	$14.52-3.2%	Jun 22, 2026
NARI Inari Medical, Inc.	Director	0	$28.5K		$85.03		Feb 20, 2025
SPRY Silverback Therapeutics, Inc.	Director	95,238	$36K		$15.25	$2.79-82%	Jun 13, 2022
EFTR eFFECTOR Therapeutics, Inc.	Director, 10% owner			$2.48M			Dec 7, 2021
LWAC eFFECTOR Therapeutics, Inc.	Director, 10% ownersince August 2021					$10.37	Oct 8, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Jonathan D Root.

Compare Jonathan D Root with

Other insiders at the same companies

Questions about Jonathan D Root

What is Jonathan D Root's role at Edgewise Therapeutics, Inc.?: Jonathan D Root reports to the SEC as director at Edgewise Therapeutics, Inc. (EWTX), according to the latest filing on July 17, 2026. Jonathan D Root has also filed as director at Omada Health, Inc. (OMDA), director at Carlsmed, Inc. (CARL), director at Inari Medical, Inc. (NARI) and director at Silverback Therapeutics, Inc. (SPRY).
How many shares does Jonathan D Root own?: After the latest filing that states it, Jonathan D Root directly owned 15,625 shares of Edgewise Therapeutics, Inc. (EWTX), 191,877 shares of Omada Health, Inc. (OMDA), 497,697 shares of Carlsmed, Inc. (CARL) and 95,238 shares of Silverback Therapeutics, Inc. (SPRY). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jonathan D Root bought or sold stock recently?: The most recent open-market purchase was on July 24, 2025: bought 466,666 shares of Carlsmed, Inc. (CARL) for $7M at an average of $15.00. The most recent open-market sale was on December 2, 2021: sold 8,113 shares of eFFECTOR Therapeutics, Inc. (EFTR) for $46.1K at an average of $5.68.
How do I get alerts when Jonathan D Root files?: Follow Jonathan D Root on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jonathan D Root (SEC CIK 0001225480). Totals count each trade once, skipping amendments whose original is on file, from Jan 21, 2021 on. View on SEC EDGAR